文献速递血脂与心血管预防冠心病心力衰竭与心肌病

心血管医学中的暗基因组

The dark genome in cardiovascular medicine.
PubMed 文献 · Eur Heart J · 2026-01-01

人类基因组仅约1%-2%直接编码蛋白质,其余非编码DNA被称为「暗基因组」,包括调控元件、转座子与重复序列、结构基因组特征、假基因、内含子及基因间区域和非编码RNA基因。该综述聚焦参与心血管疾病的主要暗基因组组分,强调机制理解与转化相关性正在显现的领域,并指出随着对暗基因组各组分机制认识的深入,靶向治疗为心血管预防和疾病管理带来新机会。

要点

  • 非编码RNA等暗基因组元件日益被认为是心血管健康和疾病的重要调控因子。
  • 基因组分析技术进步促进了对暗基因组与心血管性状关联的理解。

核心结论

  • 暗基因组元件特别是非编码RNA是心血管健康和疾病的重要调控因子,机制认识的深入正推动心血管靶向治疗的发展。

研究设计与样本

  • 综述,检索范围未在原文中明确报告。

主要发现

  • 人类基因组仅约1%-2%直接编码蛋白质,其余为非编码DNA即暗基因组。
  • 暗基因组包括调控元件、转座子和重复序列、结构基因组特征、假基因、内含子及基因间区域和非编码RNA基因。
  • 基因组分析技术的进步极大提高了对非编码区域的理解,并揭示了暗基因组与心血管性状之间更清晰的联系。

临床怎么用

  • 随着对暗基因组单个及整体组分机制认识的深入,可开发针对心血管预防和疾病管理的新型靶向治疗机会。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Only ∼1%-2% of the human genome directly codes for proteins. The remainder consists of non-coding DNA, often referred to as the 'dark genome'. This includes regulatory elements, transposable and repetitive sequences, structural genomic features, pseudogenes, intronic and intergenic regions, and non-coding RNA (ncRNA) genes. These components are increasingly recognized as major regulators of gene expression, cell identity, and disease susceptibility. Currently, dark genome elements, particularly ncRNAs are increasingly recognized as important regulators of cardiovascular health and disease. Advances in genome analysis technologies have greatly improved our understanding of these non-coding regions and revealed clearer connections between the dark genome and cardiovascular traits. This review highlights major parts of the dark genome involved in cardiovascular disease, with emphasis on those for which mechanistic understanding and translational relevance are beginning to emerge. As mechanistic insight into individual and collective components of the dark genome advances, it increasingly enables the development of new opportunities for targeted therapeutics for cardiovascular prevention and disease management.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Kesidou D, Brown SD, Maegdefessel L, et al. The dark genome in cardiovascular medicine. Eur Heart J. 2026. PMID: 42425504. doi:10.1093/eurheartj/ehag514

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。